Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Depreciation & Amortization (CF) (2023 - 2025)

Guardian Pharmacy Services' Depreciation & Amortization (CF) history spans 3 years, with the latest figure at $5.7 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 11.41% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $22.3 million, up 12.96%, while the annual FY2025 figure was $22.3 million, 12.96% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $5.7 million at Guardian Pharmacy Services, down from $5.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $5.8 million in Q3 2025 and bottomed at $4.7 million in Q4 2023.
  • The 3-year median for Depreciation & Amortization (CF) is $5.2 million (2024), against an average of $5.2 million.
  • The largest annual shift saw Depreciation & Amortization (CF) increased 9.31% in 2024 before it rose 16.9% in 2025.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $4.7 million in 2023, then rose by 9.31% to $5.2 million in 2024, then increased by 11.41% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Depreciation & Amortization (CF) are $5.7 million (Q4 2025), $5.8 million (Q3 2025), and $5.5 million (Q2 2025).